With extremely precise gene repair scientist succesfully converts the mutated allele that causes sickle cell disease into a non-pathogenic variant and...

In this week’s update, we present a CRISPR-based therapy for sickle cell disease (SCD) that has moved from the investigational new drug (IND) stage...

This week’s clinical update looks at 3 clinical trials for the treatment of sickle cell disease (SCD), relapsed or refractory blood cancers and...

With a new IND in hand, Graphite Bio plans to begin clinical trials for a CRISPR treatment that will restore normal haemoglobin expression in Sickle...

This week’s IND update looks at two distinct gene-editing strategies for sickle cell disease, both of which are set to enter clinical trials soon...

In this disease-oriented roundup, we take a look at clinical-stage gene-editing approaches to sickle cell disease, which affects millions of people...

This year CRISPR broke new ground in medicine. We saw the first CRISPR gene editing directly in the body, CRISPR took huge wins in clinical trials and...

Just 8 years after the development of CRISPR-Cas technology, Vertex Pharmaceuticals and CRISPR Therapeutics share positive clinical data for their ex...